Submission Details
| 510(k) Number | K163225 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | November 17, 2016 |
| Decision Date | August 08, 2017 |
| Days to Decision | 264 days |
| Submission Type | Traditional |
| Review Panel | Hematology (HE) |
| Summary | Summary PDF |
K163225 is an FDA 510(k) clearance for the AFIAS iFOB with AFIAS-50, a Automated Occult Blood Analyzer (Class II — Special Controls, product code OOX), submitted by Immunostics Inc., (Ocean, US). The FDA issued a Cleared decision on August 8, 2017, 264 days after receiving the submission on November 17, 2016. This device falls under the Hematology review panel. Regulated under 21 CFR 864.6550.
| 510(k) Number | K163225 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | November 17, 2016 |
| Decision Date | August 08, 2017 |
| Days to Decision | 264 days |
| Submission Type | Traditional |
| Review Panel | Hematology (HE) |
| Summary | Summary PDF |
| Product Code | OOX — Automated Occult Blood Analyzer |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 864.6550 |
| Definition | The Automated Test System Is Intended For The Qualitative Detection Of Fecal Occult Blood In Feces By Professional Laboratories. The Automated Test Is Used For The Determination Of Gastrointestinal Bleeding. |